Literature DB >> 6125188

The effect of intrinsic sympathomimetic activity on beta-receptor responsiveness after beta-adrenoceptor blockade withdrawal.

R J Walden, P Bhattacharjee, B Tomlinson, J Cashin, B R Graham, B N Prichard.   

Abstract

1 Heart rate (HR) and blood pressure (BP) changes supine, at 60 degrees tilt and in response to increasing exercise loads, and HR responses to Valsalva's manoeuvre and to isoprenaline bolus injections were studied in 19 healthy volunteers to assess the response to abrupt withdrawal of atenolol n = 6, propranolol n = 6 and pindolol n = 7. 2 The dosage of each drug administered double-blind was gradually increased over a period of 2 weeks and the dose to produce maximum inhibition of exercise-induced tachycardia was continued for one further week. 3 Plasma renin activity, plasma noradrenaline and serum free thyroid hormones were measured during control periods, maximum dosage and withdrawal periods. 4 An increased sensitivity to isoprenaline injections was seen on Day 5 after withdrawal in the atenolol treated group whereas the pindolol treated group showed decreasing hyposensitivity to isoprenaline for the 13 days of observation after withdrawal and propranolol showed an intermediate effect. 5 There was no overshoot in HR or BP measurements at rest or in response to tilting, Valsalva's manoeuvre or exercise with atenolol or propranolol and with pindolol the HR response to tilt only was significantly higher on the third day post-drug. 6 Plasma noradrenaline and serum free T3 were reduced on drug treatment and further reduced in the early withdrawal period but there were no consistent changes in plasma renin activity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6125188      PMCID: PMC1402166          DOI: 10.1111/j.1365-2125.1982.tb01941.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

1.  A sensitive radioenzymatic assay for norepinephrine in tissues and plasma.

Authors:  D P Henry; B J Starman; D G Johnson; R H Williams
Journal:  Life Sci       Date:  1975-02-01       Impact factor: 5.037

2.  A SPHYGMOMANOMETER FOR EPIDEMIOLOGISTS.

Authors:  G A ROSE; W W HOLLAND; E A CROWLEY
Journal:  Lancet       Date:  1964-02-08       Impact factor: 79.321

Review 3.  The syndrome associated with the withdrawal of beta-adrenergic receptor blocking drugs.

Authors:  B N Prichard; R J Walden
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

4.  Adrenergic hypersensitivity after beta-blocker withdrawal.

Authors:  P J Ross; M J Lewis; D J Sheridan; A H Henderson
Journal:  Br Heart J       Date:  1981-06

5.  Measurement of free thyroid hormones in serum by column adsorption chromatography and radioimmunoassay.

Authors:  P B Romelli; F Pennisi; L Vancheri
Journal:  J Endocrinol Invest       Date:  1979 Jan-Mar       Impact factor: 4.256

6.  Propranolol withdrawal and thyroid hormones in patients with essential hypertension.

Authors:  B O Kristensen; E Steiness; J Weeke
Journal:  Clin Pharmacol Ther       Date:  1978-06       Impact factor: 6.875

7.  Mechanism of propranolol withdrawal phenomena.

Authors:  S Nattel; R E Rangno; G Van Loon
Journal:  Circulation       Date:  1979-06       Impact factor: 29.690

  7 in total
  11 in total

1.  Beta-adrenoceptor blocking drugs and partial agonist activity. Is it clinically relevant?

Authors:  D G McDevitt
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

Review 2.  The syndrome associated with the withdrawal of beta-adrenergic receptor blocking drugs.

Authors:  B N Prichard; R J Walden
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

3.  Haemodynamic, metabolic, and lymphocyte beta 2-adrenoceptor changes following chronic beta-adrenoceptor antagonism.

Authors:  K Whyte; C R Jones; C A Howie; N Deighton; D J Sumner; J L Reid
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 4.  Adverse reactions and interactions with beta-adrenoceptor blocking drugs.

Authors:  R V Lewis; D G McDevitt
Journal:  Med Toxicol       Date:  1986 Sep-Oct

5.  Concentration-effect and time-effect relationships of carteolol.

Authors:  T Ishizaki; A Ohnishi; T Sasaki; K Chiba; T Suganuma; K Kushida
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Effect on heart rate over 24 hours of pindolol administered for 14 days.

Authors:  J P Kantelip; J F Trolese; P G Cromarias; P Duchêne-Marullaz
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  Withdrawal phenomena after atenolol and bopindolol: hormonal changes in normal volunteers.

Authors:  R J Walden; B Tomlinson; B Graham; C Smith; D J Betteridge; B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

8.  Withdrawal phenomena after atenolol and bopindolol: haemodynamic responses in healthy volunteers.

Authors:  R J Walden; B Tomlinson; B Graham; J B Liu; B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

9.  Effects of beta-adrenoceptor antagonist administration on beta 2-adrenoceptor density in human lymphocytes. The role of the "intrinsic sympathomimetic activity".

Authors:  O E Brodde; A Daul; N Stuka; N O'Hara; U Borchard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-02       Impact factor: 3.000

Review 10.  The pharmacokinetics of lignocaine and beta-adrenoceptor antagonists in patients with acute myocardial infarction.

Authors:  S Nattel; G Gagne; M Pineau
Journal:  Clin Pharmacokinet       Date:  1987-11       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.